Autologous cytokine-induced killer (CIK) immunotherapy in a case of disseminated tuberculosis

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jun 22;32(1):83-6.

Abstract

A 23-year-old woman had dry cough, fever and chest tightness for 1 months. Through thoracic CT scan and serological examination, the patient was clinically diagnosed as disseminated tuberculosis. she was given anti-tuberculosis therapy combined with autologous cytokine-induced killer (CIK) immunotherapy. Through the close follow-ups we found that after immunotherapy Her condition would have a swift improvement and she do not appear liver damage after a large doses of antibiotic therapy. In conclusion, adjuvant autologous CIK immunotherapy is an effective approach for disseminated tuberculosis.

Publication types

  • Case Reports

MeSH terms

  • Autografts
  • Cytokine-Induced Killer Cells / immunology
  • Cytokine-Induced Killer Cells / transplantation*
  • Female
  • Follow-Up Studies
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Quality of Life*
  • Risk Assessment
  • Severity of Illness Index
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome
  • Tuberculosis, Miliary / diagnostic imaging*
  • Tuberculosis, Miliary / physiopathology
  • Tuberculosis, Miliary / therapy*
  • Young Adult